Skip to main content
Equibles

CSS LLC/IL

Position in NBIX — Neurocrine Biosciences Inc

CIK 1103646 CHICAGO, IL
Back to NBIX Full portfolio

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,070,229
+$154,636 QoQ
Shares Held
6,350
-8.6% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#392
of 774 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Dec 31, 2021
CallValue
$0
CallShares
0
PutValue
$425,850
PutShares
5,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CSS LLC/IL holds $5,738,432 across 10 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (18.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 31,338 $1,086,488
2 NBIX
Neurocrine Biosciences Inc
This page 		6,350 $1,070,229
3 ZTS
Zoetis Inc.
 14,510 $1,042,688
4 UTHR
UNITED THERAPEUTICS Corp
 1,892 $1,025,142
5 TEVA
Teva Pharmaceutical Industries Ltd
 27,070 $917,131
6 TRLV
Trulieve Cannabis Corp.
 29,875 $293,671
7 VTRS
Viatris Inc
 11,120 $176,585
8 YCBD
cbdMD, Inc.
 137,621 $92,618

All Filings in NBIX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,070,229 6,350
2026-03-31 $915,593 6,950
2025-12-31 $229,764 1,620
2025-03-31 $300,832 2,720
2021-12-31 $425,850 5,000
2020-03-31 $8,655 100